Krabbe Disease

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies
Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
The endocannabinoid system as a target for the treatment of neurodegenerative disease
The Endocannabinoid System Is Dysregulated in Multiple Sclerosis and in Experimental Autoimmune Encephalomyelitis
Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

What are your Feelings

Still stuck? How can we help?